SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing a massive, sentiment-driven short squeeze that has triggered intense community speculation about an impending parabolic run. Investors are fiercely debating whether this rally is a sustainable mechanical event fueled by concentrated ownership or an overextended bubble destined for a volatile collapse.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community debate after a massive, rapid sell-off triggered by allegations of market manipulation and insider dumping. While some traders are attempting to scalp the token during its sharp decline, others remain deeply skeptical, comparing the rapid price cycle to previous high-profile crypto project collapses.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to a deepened partnership with NVIDIA, which integrates its QNX safety-certified software into industrial, medical, and robotic edge AI platforms. The community is actively discussing the stock's potential for a long-term revaluation, with many holders focused on the company's shift toward physical AI and autonomous systems rather than its legacy mobile business.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending as investors digest two major catalysts: the termination of a dilutive equity facility and the SEC's approval to eliminate pattern day trading (PDT) restrictions. The community is buzzing with bullish sentiment, debating the potential for a sustained breakout as retail traders rally behind the platform's competitive positioning relative to other brokerages.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is currently trending as retail investors rally behind the stock's massive short interest and potential for a rapid squeeze, while others look for catalysts in recent partnership expansions and institutional interest. Community sentiment remains deeply polarized, with bulls pointing to the company's evolving AI infrastructure pipeline and partnership strength in Asia, while bears continue to highlight governance concerns and lack of detailed guidance.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is seeing heightened volatility and active community speculation centered on its potential for a short squeeze, fueled by elevated short interest and comparisons to the price action of other rental car peers. Investors are actively tracking technical signals and options flow, specifically monitoring key resistance levels and potential institutional positioning to gauge if the stock can sustain its upward momentum.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and massive trading volume as the company intensifies its Bitcoin accumulation, positioning itself as a primary leveraged proxy for BTC price action. The community remains deeply divided, with bulls pointing to the company's aggressive BTC acquisition strategy and dividend restructuring as a catalyst for a potential squeeze, while skeptics focus on the sustainability of debt-fueled dilution and the stock's sensitivity to BTC retracements.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

The Cronos ecosystem is generating significant chatter as investors weigh the potential for institutional adoption through a proposed ETF against ongoing frustration regarding token supply dilution. While some members of the community advocate for aggressive accumulation at current levels, others express skepticism about the project's long-term performance and leadership strategy.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending following market speculation that former VP Dr. Houman Hemmati is a top candidate to lead the FDA's CBER, with the community viewing this as a significant catalyst that could accelerate the approval of Deramiocel. Investors remain highly optimistic, citing solid clinical data, an upcoming PDUFA date, and persistent short covering as the stock sustains momentum within an upward channel.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) experienced significant volatility as the community reacts to a leaked draft of the Clarity Act, which stirred concerns regarding potential restrictions on stablecoin yield programs. While traders are debating the long-term impact on Circle's revenue and the broader crypto infrastructure, market participants are actively watching for a resolution to the regulatory uncertainty as major institutional investors continue to adjust their positions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) saw a large decline in short interest in March. As of March 31st, there was short interest totaling 1,251,725 shares, a decline of 18.5% from...

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 9.7% - Should You Buy?

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 9.7% - Here's What Happened...

Jade Biosciences (NASDAQ:JBIO) Rating Increased to Hold at Zacks Research

Zacks Research raised Jade Biosciences from a "strong sell" rating to a "hold" rating in a report on Wednesday...

Jade Biosciences (NASDAQ:JBIO) Trading Up 7.9% - What's Next?

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 7.9% - What's Next...

867,284 Shares in Jade Biosciences, Inc. $JBIO Bought by Aberdeen Group plc

Aberdeen Group plc acquired a new position in shares of Jade Biosciences, Inc. (NASDAQ:JBIO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange...

Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Rating of "Moderate Buy" by Brokerages

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) has earned an average rating of "Moderate Buy" from the nine research firms that are currently covering the company, Marketbeat Ratings reports...

Jade Biosciences (NASDAQ:JBIO) Sees Unusually-High Trading Volume - Should You Buy?

Jade Biosciences (NASDAQ:JBIO) Sees Strong Trading Volume - What's Next...

HC Wainwright Lowers Earnings Estimates for Jade Biosciences

Jade Biosciences, Inc. (NASDAQ:JBIO - Free Report) - Research analysts at HC Wainwright cut their Q1 2026 EPS estimates for Jade Biosciences in a note issued to investors on Wednesday, March 25th. HC...

Jade Biosciences (NASDAQ:JBIO) Price Target Raised to $35.00 at HC Wainwright

HC Wainwright increased their target price on shares of Jade Biosciences from $25.00 to $35.00 and gave the company a "buy" rating in a research report on Wednesday...

Jade Biosciences (NASDAQ:JBIO) Shares Gap Up After Analyst Upgrade

Jade Biosciences (NASDAQ:JBIO) Shares Gap Up Following Analyst Upgrade...

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.

JBIO
Jade Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest JBIO News

JBIOJade Biosciences Inc